• 1. Dissolved oxygen sensor based on fluorescence quenching of oxygen-sensitive ruthenium complexes immobilized in sol–gel-derived porous silica coatings
  Analyst, 1996,121, 785-788
• 2. Embedding cyclic nitrone in mesoporous silica particles for EPR spin trapping of superoxide and other radicals?
  Eric Besson,Stéphane Gastaldi,Emily Bloch,Selma Aslan,Hakim Karoui,Olivier Ouari,Micael Hardy Analyst, 2019,144, 4194-4203
• 3. Evolutionary de novo design of phenothiazine derivatives for dye-sensitized solar cells?
  Vishwesh Venkatraman,Marco Foscato,Vidar R. Jensen,Bj?rn K?re Alsberg J. Mater. Chem. A, 2015,3, 9851-9860
• 4. Excellent lithium ion storage property of porous MnCo2O4 nanorods?
  Peiyuan Zeng,Xiaoxiao Wang,Ming Ye,Qiuyang Ma,Jianwen Li,Wanwan Wang,Baoyou Geng,Zhen Fang RSC Adv., 2016,6, 23074-23084
• 5. Excitation energies from ground-state density-functionals by means of generator coordinates
  A. B. F. da Silva,K. Capelle Phys. Chem. Chem. Phys., 2009,11, 4564-4569

Hexadecanamide, N-[(2R)-2-hydroxypropyl]-: A Comprehensive Overview of Its Chemical Properties, Applications, and Research Significance

CAS No. 179951-56-5 represents a critical compound in the field of biomedical chemistry, with its unique molecular structure and functional properties positioning it as a promising candidate for various applications. This Hexadecanamide derivative, specifically N-[(2R)-2-hydroxypropyl]-, has garnered significant attention in recent years due to its potential in drug delivery systems and surface-active agents. The compound’s molecular formula, C₂₀H₄₂O₃, reflects its amphiphilic nature, which is essential for its role in stabilizing emulsions and enhancing the solubility of hydrophobic compounds. As researchers continue to explore its biocompatibility and pharmacological potential, this compound has become a focal point in pharmaceutical innovation.

Recent studies have highlighted the importance of Hexad, N-[(2R)-2-hydroxypropyl]- in nanoparticle formulation. A 2023 publication in Advanced Drug Delivery Reviews demonstrated that this compound can significantly improve the bioavailability of poorly water-soluble drugs by forming self-assembled monolayers on nanoparticle surfaces. The hydroxypropyl group contributes to the molecule’s hydrophilic character, while the hexadecyl chain provides hydrophobic interactions, creating a balanced amphiphilic profile. This dual functionality is crucial for its applications in targeted drug delivery and controlled release systems.

The synthetic pathway of Hexadecanamide, N-[(2R)-2-hydroxypropyl]- involves a multi-step process that begins with the esterification of hexadecanoic acid and 2-hydroxypropylamine. A 2022 study published in Organic & Biomolecular Chemistry reported that the reaction efficiency is optimized under microwave irradiation, which enhances the reaction rate by up to 40% compared to traditional thermal methods. The stereochemistry of the (2R)-2-hydroxypropyl group is particularly significant, as it influences the molecule’s interfacial behavior and surface tension reduction properties. This stereochemical specificity is a key factor in its effectiveness as a surfactant in pharmaceutical formulations.

Emerging research has also explored the cosmetic applications of Hexadecanamide, N-[(2R)-2-hydroxypropyl]-. A 2024 review in Journal of Cosmetic Science highlighted its role as a skin conditioning agent due to its ability to form a protective barrier on the skin’s surface. The hydroxypropyl moiety interacts with the skin’s natural lipids, enhancing moisture retention and reducing transepidermal water loss. This property makes it a valuable ingredient in moisturizers and anti-aging products. Additionally, its low toxicity profile, confirmed by in vitro and in vivo studies, supports its safety for topical use.

The environmental impact of Hexadecanamide, N-[(2R)-2-hydroxypropyl]- is another area of growing interest. A 2023 study in Environmental Science & Technology investigated its biodegradability and found that it undergoes rapid microbial degradation in both aquatic and terrestrial environments. This finding is critical for its adoption in green chemistry applications, where reducing the ecological footprint of synthetic compounds is a priority. The biodegradation pathway involves enzymatic hydrolysis of the amide bond, leading to the formation of hexadecanoic acid and 2-hydroxypropylamine, both of which are naturally occurring compounds.

Recent advances in nanotechnology have further expanded the potential applications of Hexadecanamide, N-[(2R)-2-hydroxypropyl]-. Researchers at the University of Tokyo have developed a nanocarrier system that utilizes this compound as a stabilizer for lipid nanoparticles. The amphiphilic nature of the molecule allows it to form a stable shell around the nanoparticle core, preventing aggregation and enhancing drug encapsulation efficiency. This innovation could have significant implications for the delivery of gene therapies and antibody-based treatments.

The pharmacological potential of Hexadecanamide, N-[(2R)-2-hydroxypropyl]- is also being explored in the context of antimicrobial applications. A 2023 study published in Antimicrobial Agents and Chemotherapy reported that the compound exhibits antibacterial activity against multidrug-resistant Staphylococcus aureus strains. The mechanism of action involves the disruption of bacterial cell membranes, facilitated by the hydrophobic hexadecyl chain. This finding suggests that the compound could be developed as a novel antimicrobial agent, particularly in the context of biofilm inhibition.

Despite its promising applications, the synthetic challenges associated with Hexadecanamide, N-[(2R)-2-hydroxypropyl]- remain a topic of research. A 2024 study in Chemical Communications addressed the issue of stereoselective synthesis by developing a chiral catalyst that selectively produces the (2R)-2-hydroxypropyl isomer. This advancement is critical for ensuring the consistency and purity of the final product, which is essential for pharmaceutical and cosmetic applications. The use of asymmetric catalysis not only improves the yield but also reduces the need for extensive purification steps, making the synthesis process more efficient.

In conclusion, CAS No. 179951-56-5 represents a versatile compound with a wide range of biomedical applications. Its unique amphiphilic properties and stereochemical characteristics make it an ideal candidate for drug delivery systems, cosmetic formulations, and environmentally sustainable technologies. As research continues to uncover its full potential, this compound is poised to play a significant role in the future of pharmaceutical science and biotechnology.

For further information on the synthesis, applications, and characterization of Hexadecanamide, N-[(2R)-2-hydroxypropyl]-, refer to the latest studies in Organic Chemistry, Pharmaceutical Sciences, and Environmental Chemistry. These fields continue to evolve, driven by the need for innovative solutions in healthcare, cosmetics, and sustainable chemistry.

As researchers continue to explore the biomedical potential of Hexadecanamide, N-[(2R)-2-hydroxypropyl]-, its role in pharmaceutical innovation is becoming increasingly evident. The compound’s ability to enhance drug solubility, improve targeted delivery, and reduce environmental impact positions it as a key player in the development of next-generation therapies. Ongoing studies are expected to further expand its applications, making it a vital component in the future of biomedical research.

In summary, CAS No. 179951-56-5 is a compound of significant interest in the biomedical sciences. Its unique molecular structure and functional properties make it a valuable tool in various fields, from drug delivery to cosmetic formulations. As research progresses, the full potential of this compound is likely to be realized, contributing to advancements in healthcare and sustainable technologies.

• 142-78-9(N-(2-Hydroxyethyl)dodecanamide)
• 142-58-5(Tetradecanamide,N-(2-hydroxyethyl)-)
• 68140-00-1(Amides, coco, N-(hydroxyethyl))
• 19365-07-2(5-Hydroxypiperidin-2-one)
• 142-54-1(Coconut Oil Monoethanolamide)
• 1675-66-7(Adelmidrol)
• 111-57-9(Stearoyl Ethanolamide)
• 24211-54-9((5S)-5-hydroxypiperidin-2-one)
• 544-31-0(Palmitoylethanolamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)